Skip to main content

Peer Review reports

From: Provision of pharmaceutical care to suspected high-risk COVID-19 patients through telehealth: a nationwide simulated patient study

Original Submission
17 Apr 2021 Submitted Original manuscript
30 May 2021 Reviewed Reviewer Report
21 Jun 2021 Reviewed Reviewer Report
5 Jul 2021 Reviewed Reviewer Report
26 Jul 2021 Author responded Author comments - Samar Karout
Resubmission - Version 2
26 Jul 2021 Submitted Manuscript version 2
30 Jul 2021 Author responded Author comments - Samar Karout
Resubmission - Version 3
30 Jul 2021 Submitted Manuscript version 3
5 Aug 2021 Reviewed Reviewer Report
6 Aug 2021 Reviewed Reviewer Report
13 Aug 2021 Reviewed Reviewer Report
4 Sep 2021 Author responded Author comments - Samar Karout
Resubmission - Version 4
4 Sep 2021 Submitted Manuscript version 4
8 Sep 2021 Author responded Author comments - Samar Karout
Resubmission - Version 5
8 Sep 2021 Submitted Manuscript version 5
Publishing
9 Sep 2021 Editorially accepted
21 Sep 2021 Article published 10.1186/s12913-021-07014-x

You can find further information about peer review here.

Back to article page